InvestorsHub Logo
Post# of 176736
Next 10
Followers 18
Posts 2848
Boards Moderated 0
Alias Born 09/15/2014

Re: LonghornSean post# 149007

Friday, 08/12/2022 10:49:38 PM

Friday, August 12, 2022 10:49:38 PM

Post# of 176736
Easily. There’s lots of eyes on this. Any brokerage firm that has anything to do with new medical and what not want in on this. Only problem is that they can only buy in at certain price ranges.

People don’t realize what they are holding when it comes to price. I understand being conservative and all but fda plays skyrocket all of the time. I’m talking 300% plus.

With this you have a few possibilities with price increases, that’s if the doc mentions all of them.

1. Animal test is finalized set meeting with fda for review. There’s a possibility of a slight increase here or this very well could start the launch.

2. Fda board gives a thumbs up to submit ide application.

3, announces ide application submittal now 30 days of increases and retreats.

4. Ide approval.

5. Announces strat of human trials.

Now with all of this going on, there’s still strong interest overseas and some have mentioned that they will start things when farther along with the ide. This here is very vague and possible but won’t know until there’s a pr.

And of course isopet, yes Sc8 I know this is a ide play. But pending on how many new clinics are announced that could possibly get this whole ball rolling, I’m not talking a huge price increase but it could push us up into the. .10 to .20 range. Right before announcing anything to do with the ide would be nice but time will tell.




So this being a tripl on ide alone a very huge possibility.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDGL News